Filed 2mo ago· Apr 3, 2026
14 days to disclose
Kevin Hern
RHouseOklahoma-01
↓sold
Medtronic
MDT
$15K-$50K
+2.2% vs S&P 500
Trade dateMar 20, 2026
⚑ Healthcare
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.



































| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Apr 3, 2026 2mo ago | ![]() Kevin Hern RHouseOklahoma-01 | ↓sold | Medtronic MDT ⚑ Healthcare · Ways and Means | Mar 20, 2026 14 days to disclose | Flat·+0.0% +2.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 3, 2026 2mo ago | ![]() Kevin Hern RHouseOklahoma-01 | ↓sold | Becton Dickinson BDX Common Stock ⚑ Healthcare · Ways and Means | Mar 17, 2026 17 days to disclose | Flat·+0.0% −0.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 3, 2026 2mo ago | ![]() Kevin Hern RHouseOklahoma-01 | ↓sold | Kenvue KVUE ⚑ Healthcare · Ways and Means | Mar 17, 2026 17 days to disclose | Flat·+0.0% −0.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 3, 2026 2mo ago | ![]() Kevin Hern RHouseOklahoma-01 | ↓sold | IQVIA Holdings IQV JT IQVIA Holdings, Inc. ⚑ Healthcare · Ways and Means | Mar 16, 2026 18 days to disclose | Flat·+0.0% −1.7% vs S&P 500 | $50K-$100K midpoint $75K |
Apr 3, 2026 2mo ago | ![]() Kevin Hern RHouseOklahoma-01 | ↓sold | ICON plc ICLR JT ICON plc - Ordinary Shares ⚑ Healthcare · Ways and Means | Mar 5, 2026 29 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $100K-$250K midpoint $175K |
Mar 6, 2026 2mo ago | ![]() Kevin Hern RHouseOklahoma-01 | ↔exchanged | Waters WAT ⚑ Healthcare · Ways and Means | Feb 9, 2026 25 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 22, 2026 4mo ago | ![]() Kevin Hern RHouseOklahoma-01 | ↓sold | UnitedHealth Group UNH Common Stock ⚑ Healthcare · Ways and Means | Dec 23, 2025 30 days to disclose | Flat·+0.0% −4.2% vs S&P 500 | $250K-$500K midpoint $375K |
Nov 16, 2025 6mo ago | ![]() Kevin Hern RHouseOklahoma-01 | ↓sold | Boston Scientific BSX Common Stock ⚑ Healthcare · Ways and Means | Oct 28, 2025 19 days to disclose | Flat·+0.0% +2.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jan 15, 2025 1.4y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↓sold | Dexcom DXCM ⚑ Healthcare · Ways and Means | Dec 31, 2024 15 days to disclose | Flat·+0.0% +8.0% vs S&P 500 | $50K-$100K midpoint $75K |
Jul 15, 2024 1.9y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | UnitedHealth Group UNH Common Stock ⚑ Healthcare · Ways and Means | Jun 25, 2024 20 days to disclose | Bad buy·−$2.1K-26.7% −57.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 12, 2024 2.1y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | UnitedHealth Group UNH Common Stock ⚑ Healthcare · Ways and Means | Mar 19, 2024 24 days to disclose | Bad buy·−$2.2K-28.1% −66.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2024 2.4y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | UnitedHealth Group UNH Common Stock ⚑ Healthcare · Ways and Means | Dec 12, 2023 32 days to disclose | Bad buy·−$2.8K-35.0% −88.8% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 13, 2023 2.6y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | UnitedHealth Group UNH Common Stock ⚑ Healthcare · Ways and Means | Sep 19, 2023 24 days to disclose | Bad buy·−$1.7K-20.8% −33.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 12, 2023 2.9y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | UnitedHealth Group UNH Common Stock ⚑ Healthcare · Ways and Means | Jun 27, 2023 15 days to disclose | Bad buy·−$2.1K-26.5% −90.1% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 10, 2023 3.2y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | UnitedHealth Group UNH Common Stock ⚑ Healthcare · Ways and Means | Mar 21, 2023 20 days to disclose | Bad buy·−$1.7K-20.7% −36.9% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2023 3.3y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↓sold | Thermo Fisher Scientific TMO ⚑ Healthcare · Ways and Means | Jan 31, 2023 14 days to disclose | Smart sell·+$1.4K+17.6% +93.3% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2023 3.3y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↓sold | Danaher DHR ⚑ Healthcare · Ways and Means | Jan 31, 2023 14 days to disclose | Smart sell·+$2K+24.4% +100.0% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2023 3.3y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↓sold | ICON plc ICLR JT ICON plc - Ordinary Shares ⚑ Healthcare · Ways and Means | Jan 31, 2023 14 days to disclose | Smart sell·+$4.5K+55.7% +131.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2023 3.3y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↓sold | Medtronic MDT ⚑ Healthcare · Ways and Means | Jan 31, 2023 14 days to disclose | Flat·+0.0% +11.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2023 3.4y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | UnitedHealth Group UNH Common Stock ⚑ Healthcare · Ways and Means | Dec 13, 2022 31 days to disclose | Bad buy·−$2.7K-34.1% −111.7% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2022 3.6y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | UnitedHealth Group UNH Common Stock ⚑ Healthcare · Ways and Means | Sep 20, 2022 20 days to disclose | Bad buy·−$2K-25.1% −44.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 12, 2022 4.1y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | IQVIA Holdings IQV ⚑ Healthcare · Ways and Means | Apr 30, 2022 12 days to disclose | Bad buy·−$1.5K-18.9% −33.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 12, 2022 4.1y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | UnitedHealth Group UNH Common Stock ⚑ Healthcare · Ways and Means | Mar 22, 2022 21 days to disclose | Bad buy·−$2K-24.6% −33.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 11, 2022 4.4y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↓sold | Medtronic MDT ⚑ Healthcare · Ways and Means | Dec 20, 2021 22 days to disclose | Smart sell·+$28.5K+16.3% +73.2% vs S&P 500 | $100K-$250K midpoint $175K |
Jan 11, 2022 4.4y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | UnitedHealth Group UNH Common Stock ⚑ Healthcare · Ways and Means | Dec 14, 2021 28 days to disclose | Bad buy·−$1.6K-20.6% −30.3% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 7, 2021 4.7y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | Medtronic MDT ⚑ Healthcare · Ways and Means | Sep 23, 2021 14 days to disclose | Bad buy·−$62.9K-35.9% −97.0% vs S&P 500 | $100K-$250K midpoint $175K |
Sep 15, 2021 4.7y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | Thermo Fisher Scientific TMO ⚑ Healthcare · Ways and Means | Jul 21, 2021 56 days to disclose · 11 past 45-day window | Bad buy·−$6.5K-8.7% −73.0% vs S&P 500 | $50K-$100K midpoint $75K |
Sep 15, 2021 4.7y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | Danaher DHR ⚑ Healthcare · Ways and Means | Jul 1, 2021 76 days to disclose · 31 past 45-day window | Bad buy·−$47.7K-27.3% −44.2% vs S&P 500 | $100K-$250K midpoint $175K |
Sep 15, 2021 4.7y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | Medtronic MDT ⚑ Healthcare · Ways and Means | Jul 1, 2021 76 days to disclose · 31 past 45-day window | Bad buy·−$11K-33.9% −99.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 15, 2021 5.0y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | IQVIA Holdings IQV ⚑ Healthcare · Ways and Means | May 20, 2021 26 days to disclose | Bad buy·−$2.5K-31.5% −103.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 15, 2021 5.0y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | Boston Scientific BSX ⚑ Healthcare · Ways and Means | May 20, 2021 26 days to disclose | Good buy·+$3.8K+48.1% −23.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 15, 2021 5.0y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | Boston Scientific BSX ⚑ Healthcare · Ways and Means | May 20, 2021 26 days to disclose | Good buy·+$3.8K+48.1% −23.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 15, 2021 5.0y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | IQVIA Holdings IQV ⚑ Healthcare · Ways and Means | May 20, 2021 26 days to disclose | Bad buy·−$2.5K-31.5% −103.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 15, 2021 5.0y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | IQVIA Holdings IQV ⚑ Healthcare · Ways and Means | May 20, 2021 26 days to disclose | Bad buy·−$2.5K-31.5% −103.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 15, 2021 5.0y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | Boston Scientific BSX ⚑ Healthcare · Ways and Means | May 20, 2021 26 days to disclose | Good buy·+$3.8K+48.1% −23.8% vs S&P 500 | $1K-$15K midpoint $8K |